Innohep

Innohep is a brand name of tinzaparin, approved by the FDA in the following formulation(s):

INNOHEP (tinzaparin sodium - injectable; injection)

• 
  Manufacturer: LEO PHARMA AS
  
  Approval date: July 14, 2000
  
  Strength(s): 20,000 IU/ML ^[RLD]

Has a generic version of Innohep been approved?

No. There is currently no therapeutically equivalent version of Innohep available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Innohep. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Innohep.

See also...

• Innohep Consumer Information (Wolters Kluwer)
• Innohep Consumer Information (Cerner Multum)
• Innohep Advanced Consumer Information (Micromedex)
• Innohep AHFS DI Monographs (ASHP)
• Tinzaparin Consumer Information (Wolters Kluwer)
• Tinzaparin Consumer Information (Cerner Multum)
• Tinzaparin Subcutaneous Advanced Consumer Information (Micromedex)
• Tinzaparin Sodium AHFS DI Monographs (ASHP)